Event brings together experts from across the profession
The Animal Welfare Foundation (AWF) has marked 35 years with a day of thought-provoking debates and inspiring discussions.
More than 200 delegates from across the veterinary, academic and animal welfare sectors met in London on 12 June to exchange views on some of the most pressing issues affecting animal welfare. Topics included the role of insurance in impacting pets’ quality of life, human behaviour change to improve animal welfare and pre-purchase consultations for prospective pet owners.
Addressing the audience, AWF Chair of Trustees Chris Laurence said: “What unites all of us here at the conference is our concern for animal welfare. Through the Discussion Forum, we debate difficult issues and explore new ways in which the veterinary profession might use its position and influence for a broader public understanding of animal welfare.
“The human-animal relationship is changing, bringing new dynamics to animal welfare and challenging the way the veterinary profession uses the broad range of skills of modern vets and nurses. For vets to become leaders in preventative care means learning new skills and balancing their technical ability with the welfare of their patients.”
During the event, BVA president John Fishwick updated the audience on the organisation’s recent campaign successes on Brexit-related animal welfare issues.
“With less than a year to go before Brexit, it is important that we continue to raise awareness around the vital role the veterinary profession plays in upholding animal welfare and to ensure that vets’ voices are heard in new legislation introduced in this area,” he said. “I was very pleased to have the opportunity to share BVA’s ongoing work at this exceptional conference.”
The event was followed by a joint BVA and AWF reception at the House of Commons, hosted by Neil Parish MP.
Image (C) AWF
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
